Financing Drugs in South-East Asia - Report of the First Meeting of the WHO/SEARO Working Group on Drug Financing, Korat, Thailand, 26-28 November 1996 - Health Economics and Drugs Series No. 004
(1997; 72 pages)

Table of Contents

	Executive summary
		Background
		Drug financing issues
		Cost-sharing for drugs
		Monitoring for equity and quality
		Conclusions and recommendations
		Workshop evaluation
	1. Introduction
		1.1 Opening session
		1.2 Background
		1.3 Objectives of the Working Group
	2. Country presentations on drug financing
		2.1 Indonesia (presented by Dra Andayaningsih)
		2.2 Myanmar (presented by Dr Than Zaw)
		2.3 Nepal (presented by Dr Singh Karki)
		2.4 Thailand (presented by Dr Porntep Siriwanarangsun)
		2.5 Summary
	3. Korat provincial field visit
		3.1 Soongnern Community Hospital
		3.2 Maa Kleur Kao Health Centre
		3.3 Village drug funds (or drug cooperatives)
	4. Drug financing issues
		4.1 Drug financing alternatives (by Dr German Velasquez)
		4.2 Cost-sharing for drugs (by Dr Petcharat Pongcharoensuk)
		4.3 Monitoring for equity and quality (by Dr Jonathan Quick)
	5. Country priorities for drug financing
		5.1 Indonesia
		5.2 Myanmar
		5.3 Nepal
		5.4 Thailand
	6. Priorities for work group action
		6.1 Group A
		6.2 Group B
	7. Conclusions and recommendations
		7.1 Country priorities for action
		7.2 Recommendations
	Annex A. Agenda
	Annex B. List of participants
	Annex C. List of documents
	Annex D. Message from Regional Director, WHO South-East Asia Region
	Annex E. Evaluation of the meeting. Priorities for the Working Group
		1. Evaluation of the meeting
		2. Priorities for the next Working Group meeting

Financing Drugs in South-East Asia - Report of the First Meeting of the WHO/SEARO Working Group on Drug Financing, Korat, Thailand, 26-28 November 1996 - Health Economics and Drugs Series No. 004

SEA/Drugs/118

Action Programme on Essential Drugs
Geneva

Regional Office for South-East Asia
New Delhi

© World Health Organization 1997

This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).

The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means -electronic, mechanical or other -without the prior permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

Abbreviations

AFTA	The Asian Free Trade Agreement
BNMT	British-Nepal Medical Trust
CCS	Community cost-sharing
CMSD	Central Medical Store Depot
CSMBS	Civil Servant Medical Benefit Scheme
DAP	Drug Action Programme, Action Programme on Essential Drugs
ED	Essential drugs
FDA	Food and Drug Administration
GDP	Gross domestic product
GMP	Good manufacturing practices
GPO	Government Pharmaceutical Organization
HC	Health centre
HDS	Hill Drug Scheme
HMG	His Majesty's Government (Nepal)
INGO	International nongovernmental organization
INO	Indonesia
km.	kilometres
MMR	Myanmar
MOH	Ministry of Health
MOPH	Ministry of Public Health
MSH	Management Sciences for Health
NED	Non-essential drugs
NEDL	National essential drugs list
NEP	Nepal
NGO	Nongovernmental organization
NLR	The Netherlands Leprosy Relief
OPD	Outpatients department
PHC	Primary health care
RHC	Rural health centre
Rp	Rupiahs
Rs	Rupees
SEAR	South-East Asia Region
SEARO	South-East Asia Regional Office
sq. km.	square kilometres
THA	Thailand
TRIPS	Trade-Related Intellectual Property Rights
UMN	United Missions to Nepal
UNICEF	United Nations Children's Fund
USAID	United States Agency for International Development
WCS	Workman Compensation Scheme
WHO	World Health Organization

Current exchange rate to one US$ (November 1996)

Country	Amount in national currency
Indonesia	Rupiahs	2 330
Myanmar	Kyats	5.88
Nepal	Rupees	56.80
Thailand	Bahts	25.40